Category:
Business
The global clinical biomarkers market is forecasted to grow at a rate of 13.3% in terms of value, from USD 45.69 billion in 2019 to reach USD 124.51 billion by 2027. High cancer prevalence promotes research initiatives to drive market development. Extensive work and technical advancements used to develop biomarker-based clinical diagnostics are expected to be significant market contributors



